Circulating tumor cells: A surrogate to predict the effect of treatment and overall survival in gastric adenocarcinoma

Abstract

Generally, circulating tumor cells provide a novel tool to evaluate the outcomes of gastric cancer patients. Since the change of circulating tumor cells was highly related to treatment response, it may be an auxiliary to assess the effect of chemotherapy, leading an earlier adjustment of following regimens.